Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-04-21 8:16:4 am | XBI: Uncorrelated Growth Capitalizing On The M&A Tidal Wave In Pharma | SeekingAlpha |
| 2023-04-11 1:14:29 pm | Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information | Benzinga |
| 2023-04-04 1:2:8 am | Strength Seen in Apellis Pharmaceuticals, Inc. (APLS): Can Its 16.3% Jump Turn into More Strength? | Zacks |
| 2023-04-02 5:45:16 am | Provention Bio, Inc. (NASDAQ:PRVB) Just Reported And Analysts Have Been Cutting Their Estimates | Simply Wall St. |
| 2023-03-25 4:15:0 am | Is Sanofi Stock a Buy Now? | Motley Fool |
| 2023-03-17 11:52:22 pm | MacroGenics, Inc. (NASDAQ:MGNX) Q4 2022 Earnings Call Transcript | Insider Monkey |
| 2023-03-16 1:56:47 pm | Why Provention Bio Stock Skyrocketed 256% This Week | Motley Fool |
| 2023-03-16 4:10:4 am | Q4 2022 MacroGenics Inc Earnings Call | Thomson Reuters StreetEvents |
| 2023-03-14 9:32:4 am | Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi | Zacks |
Please consider a small donation if you think this website provides you with relevant information